Articles with public access mandates - Dante Rotili, PhDLearn more
OverallGovernment of ItalyAIRC Foundation for Cancer Research in ItalyEuropean CommissionNIHFondazione CariploINSERMNWODFGANRDOENHMRCCIHRGenome CanadaSwedish Research CouncilCancer Research UKEPSRCMRCWorldwide Cancer Research, UKGovernment of SpainCPRITFAPESPSNSFVAFNRSSFIVersus Arthritis, UKBBSRCBHFWellcomeLeducq Foundation, USA
Not available anywhere: 15
Structural basis of sirtuin 6 activation by synthetic small molecules
W You, D Rotili, TM Li, C Kambach, M Meleshin, M Schutkowski, KF Chua, ...
Angewandte Chemie International Edition 56 (4), 1007-1011, 2017
Mandates: US National Institutes of Health, US Department of Veterans Affairs, German …
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities
D Rotili, S Tomassi, M Conte, R Benedetti, M Tortorici, G Ciossani, ...
Journal of medicinal chemistry 57 (1), 42-55, 2014
Mandates: Fondazione Cariplo, Government of Italy
Lysine deacetylase inhibitors in parasites: past, present, and future perspectives
GS Hailu, D Robaa, M Forgione, W Sippl, D Rotili, A Mai
Journal of Medicinal Chemistry 60 (12), 4780-4804, 2017
Mandates: Fondazione Cariplo, European Commission, Government of Italy
Non-Cancer Uses of Histone Deacetylase Inhibitors: Effects on Infectious Diseases and β-Hemoglobinopathies+
D Rotili, G Simonetti, A Savarino, AT Palamara, AR Migliaccio, A Mai
Current Topics in Medicinal Chemistry 9 (3), 272-291, 2009
Mandates: US National Institutes of Health
Identification of novel quinazoline derivatives as potent antiplasmodial agents
A Bouchut, D Rotili, C Pierrot, S Valente, S Lafitte, J Schultz, U Hoglund, ...
European Journal of Medicinal Chemistry 161, 277-291, 2019
Mandates: US National Institutes of Health, National Health and Medical Research …
Sirtuin modulators: where are we now? A review of patents from 2015 to 2019
N Mautone, C Zwergel, A Mai, D Rotili
Expert Opinion on Therapeutic Patents 30 (6), 389-407, 2020
Mandates: US National Institutes of Health, Government of Italy, AIRC Foundation for …
Targeting histone acetylation/deacetylation in parasites: an update (2017–2020)
R Fioravanti, N Mautone, A Rovere, D Rotili, A Mai
Current Opinion in Chemical Biology 57, 65-74, 2020
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
Lysine acetyltransferase inhibitors: structure–activity relationships and potential therapeutic implications
F Fiorentino, A Mai, D Rotili
Future Medicinal Chemistry 10 (9), 1067-1091, 2018
Mandates: European Commission, Government of Italy
Effect of α-Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3H)-ones
MB Nawrozkij, M Forgione, AS Yablokov, A Lucidi, D Tomaselli, ...
Journal of Medicinal Chemistry 62 (2), 604-621, 2018
Mandates: Government of Spain
Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approaches
M Sabatino, D Rotili, A Patsilinakos, M Forgione, D Tomaselli, F Alby, ...
Journal of Computer-Aided Molecular Design 32, 435-458, 2018
Mandates: US National Institutes of Health, Fondazione Cariplo, Government of Italy
Recent advances in epigenetic proteolysis targeting chimeras (Epi-PROTACs)
D Tomaselli, N Mautone, A Mai, D Rotili
European Journal of Medicinal Chemistry 207, 112750, 2020
Mandates: US National Institutes of Health, Government of Italy, AIRC Foundation for …
Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages
B Noce, E Di Bello, C Zwergel, R Fioravanti, S Valente, D Rotili, A Masotti, ...
ChemMedChem 18 (3), e202200510, 2023
Mandates: Swiss National Science Foundation
Multimodal evaluation of 19F-BPA internalization in pancreatic cancer cells for boron capture and proton therapy potential applications
A Ciardiello, S Altieri, F Ballarini, V Bocci, S Bortolussi, L Cansolino, ...
Physica Medica 94, 75-84, 2022
Mandates: Government of Italy
Mass spectrometry characterization of dota-nimotuzumab conjugate as precursor of an innovative β− tracer suitable in radio-guided surgery
C Martelli, V Marzano, F Marini, T Scotognella, I Fratoddi, I Venditti, ...
Journal of Pharmaceutical and Biomedical Analysis 156, 8-15, 2018
Mandates: Fondazione Cariplo
Comparison of the effects of synthetic and plant-derived mTOR regulators on healthy human ovarian cells
AV Sirotkin, E Adamcova, D Rotili, A Mai, M Mlyncek, L Mansour, ...
European Journal of Pharmacology 854, 70-78, 2019
Mandates: Government of Italy
Available somewhere: 94
Sirtuin functions and modulation: from chemistry to the clinic
V Carafa, D Rotili, M Forgione, F Cuomo, E Serretiello, GS Hailu, E Jarho, ...
Clinical epigenetics 8, 1-21, 2016
Mandates: Fondazione Cariplo, European Commission, Government of Italy
SIRT5 regulation of ammonia-induced autophagy and mitophagy
L Polletta, E Vernucci, I Carnevale, T Arcangeli, D Rotili, S Palmerio, ...
Autophagy 11 (2), 253-270, 2015
Mandates: Government of Italy
Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue
A Galmozzi, N Mitro, A Ferrari, E Gers, F Gilardi, C Godio, G Cermenati, ...
diabetes 62 (3), 732-742, 2013
Mandates: US National Institutes of Health, Fondazione Cariplo
p300/CBP-associated factor selectively regulates the extinction of conditioned fear
W Wei, CM Coelho, X Li, R Marek, S Yan, S Anderson, D Meyers, ...
Journal of Neuroscience 32 (35), 11930-11941, 2012
Mandates: US National Institutes of Health, National Health and Medical Research …
Development of 1, 2, 4-oxadiazoles as potent and selective inhibitors of the human deacetylase sirtuin 2: structure–activity relationship, X-ray crystal structure, and …
S Moniot, M Forgione, A Lucidi, GS Hailu, A Nebbioso, V Carafa, F Baratta, ...
Journal of medicinal chemistry 60 (6), 2344-2360, 2017
Mandates: Worldwide Cancer Research, UK, European Commission, Government of Italy
Publication and funding information is determined automatically by a computer program